Nabilone Use in Dementia Management

Critical Safety Concerns

• The American Geriatrics Society notes that nabilone carries high risks for elderly dementia patients, including high incidence of cognitive impairment, sedation, dizziness, and drowsiness 1, 2
• Ataxia and postural hypotension occur frequently with nabilone use, making older persons prone to falls from orthostatic changes 1, 2
• Cardiovascular effects, including potential arrhythmias, are associated with THC and cannabidiol compounds 1, 2
• Cognitive worsening is a major concern when using nabilone in patients with underlying diseases that cause progressive cognitive decline 1, 2

Evidence Base and Guidelines

• The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines state that systematic use of appetite stimulants, including cannabinoids, cannot be recommended due to limited evidence and potentially harmful side effects 3
• The American Academy of Family Physicians recommends non-pharmacologic interventions, such as providing predictable routines and simplifying tasks, before medication trials 4
• Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, may improve neuropsychiatric symptoms in dementia patients and are recommended as first-line pharmacologic therapy 4, 5, 6
• The American Academy of Family Physicians recommends SSRIs, such as citalopram and sertraline, for agitation and neuropsychiatric symptoms that persist despite non-pharmacologic interventions 4

Safe Use and Alternatives

• The American Geriatrics Society strongly recommends avoiding antipsychotics in older adults with dementia due to increased mortality risk, and limiting their use to those exhibiting hazards to self or others 5
• If antipsychotics are used, attempt discontinuation after 3 months, as Cochrane evidence shows successful tapering with no change in behavioral symptoms in many cases 5
• Nabilone is FDA-approved only for chemotherapy-induced nausea and vomiting, not for dementia or behavioral symptoms, and its use in elderly patients requires careful monitoring of ataxia, cognitive effects, and sedation 1, 2